30 Jan, EOD - Indian

SENSEX 76759.81 (0.30)

Nifty 50 23249.5 (0.37)

Nifty Bank 49311.95 (0.30)

Nifty IT 42426.65 (-1.14)

Nifty Midcap 100 52714.25 (-0.01)

Nifty Next 50 62193.15 (0.08)

Nifty Pharma 21419.65 (1.21)

Nifty Smallcap 100 16560.5 (0.12)

30 Jan, EOD - Global

NIKKEI 225 39513.97 (0.25)

HANG SENG 20225.11 (0.14)

S&P 6113.5 (0.04)

LOGIN HERE

companylogo

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : | NSE Symbol : | ISIN : | Industry : |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
21-Jan-2025 27-Jan-2025 Quarterly Results Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve Financial results for the quarter ended 31.12.2024 Results for the quarter ended 31.12.2024 (As Per BSE Announcement Dated on 27/01/2025)
03-Dec-2024 11-Dec-2024 Stock Split Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2024 inter alia to consider and approve 1. Sub-division of the equity shares of the Company of face value of Rs.10/- each pursuant to the provisions of Section 61(1)(d) of Companies Act 2013 and other applicable provisions if any. 2. To take prior approval to purchase land admeasuring 2.06 Guntas and 22000 Sq. feet constructed warehouse located at Jangaon Telangana from Related party/ies. 3. Modification in the Remuneration of Mr. Pabbathi Badri Narayana Murthy Whole-time Director of the Company. Outcome Of Board Meeting Held On 11.12.2024 The Board considered the proposal for sub-division of 1(one) Equity share of the Company having face value of Rs. 10/- each into 10 (Ten) Equity shares having face value of Re. 1/- each, subject to regulatory/statutory approvals as may be required and the approval of the shareholders of the Company. Due to typographical error, filing the revised outcome (As Per BSE Announcement Dated on 11.12.2024)
05-Nov-2024 12-Nov-2024 Quarterly Results Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Unaudited financial results for the quarter ended 30.09.2024 Unaudited Results for the Quarter ended 30.09.2024 (As Per BSE Announcement Dated on 12.11.2024)
03-Aug-2024 12-Aug-2024 Quarterly Results Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Intimation For Unaudited Financial Results for quarter ended 30.06.2024 Unaudited Financial results For Quarter ended 30.06.2024 (As Per BSE Announcement Dated on 12.08.2024)
18-Jun-2024 18-Jun-2024 Others BOARD MEETING FOR APPROVING INCREASE IN REMUMERATION OF WHOLE TIME DIRECTOR AND INCREASE IN SITTING FEES OF NON-EXECUTIVE DIRECTORS
14-May-2024 30-May-2024 Accounts Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve AUDITED FINANCIAL RESULTS AUDIT REPORT Audited Financial Results for the Year ended 31.03.2024 (As Per BSE Announcement Dated on 30.05.2024)
02-Feb-2024 10-Feb-2024 Quarterly Results Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve Unaudited financial results for the quarter ended 31.12.2023.
18-Nov-2023 18-Nov-2023 Right Issue Outcome of Board Meeting held on 18.11.2023
25-Oct-2023 31-Oct-2023 Quarterly Results Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 inter alia to consider and approve Unaudited financial results for the quarter ended 30.09.2023. Outcome of Board Meeting held on 31.10.2023 (As Per BSE Announcement dated on 31.10.2023)
06-Sep-2023 06-Sep-2023 AGM Outcome of Board Meeting held on 06.09.2023
18-Jul-2023 25-Jul-2023 Quarterly Results Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2023 inter alia to consider and approve Unaudited financial results for the quarter ended 30.06.2023. Approval of Unaudited financial results for the quarter ended 30.06.2023 (As Per BSE Announcement dated on 25.07.2023)
14-Jun-2023 17-Jun-2023 Right Issue Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/06/2023 inter alia to consider and approve To discuss on the terms of the Rights Issue including the size of the Rights Issue and number of securities proposed to be issued.
08-May-2023 29-May-2023 Accounts Arunjyoti Bio Ventures Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve Consideration of Audited Financial Results for the Quarter and Year ended 31.03.2023
10-Apr-2023 14-Apr-2023 Expansion Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/04/2023 inter alia to consider and approve Raising of funds for expansion of business Outcome of Board meeting held on 14.04.2023 (As per BSE Announcement Dated on 14/04/2023)
18-Jan-2023 27-Jan-2023 Quarterly Results Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2023 inter alia to consider and approve Approval of un-audited financial results for the quarter ended 31.12.2022 Financial results for the quarter ended 31.12.2022 (As Per BSE Announcement dated on 27.01.2023)
1 2 3 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +